✦ LIBER ✦

PMS18 A BUDGET IMPACT MODEL FOR THE ECONOMIC ASSESSMENT OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS IN ITALY

✍ Scribed by S Iannazzo; O Zaniolo; G Giuliani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS12 A Budget Impact Model for the Use

✍ S. Iannazzo; G. Didoni; D. Crocchiolo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS39 Economic Evaluation of Tocilizumab

✍ F. Carlos; P. Clark; D. Lechuga 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS46 Economic Evaluation of Adalimumab

✍ A. Benedict; T. Kongnakorn; J.W. Shaw; A. Marcellusi; D.J. Vanness; L. Gitto; P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS35 Cost-Effectiveness of Tocilizumab

✍ I. Ertenli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMS30 Cost-Effectiveness of Tocilizumab

✍ A. Diamantopoulos; S. Andrade; A. Bernardo; J. Branco; L. Inês; J.A. Pereira da 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS12 Budget Impact of Golimumab in the

✍ A.D. Morais; M.L. Pereira 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB